Form 4 for WVE Wave Life Sciences, Inc.
Accepted 2026-08-13 21:00:10 ET · period of report 2026-08-11 · accession 0001193125-26-349963 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-13 21:00 | 2026-08-11 | WVE | Wagner Heidi L | Dir | M - OptEx | $5.97 | +7,000 | 51.9K | +16% | +$41.8K |
| DT | 2026-08-13 21:00 | 2026-08-11 | WVE | Wagner Heidi L | Dir | S - Sale+OE | $6.01 | -7,000 | 44.9K | -13% | -$42.1K |
| DT | 2026-08-13 21:00 | 2026-08-11 | WVE | Wagner Heidi L | Dir | M - OptEx | $0.00 | -7,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-11 | M | A | 7,000 | $5.97 | 51,930 | D | — | — | (F1) The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. |
| 2 | Common | Common Stock | 2026-08-11 | S | D | 7,000 | $6.01 | 44,930 | D | — | — | (F1) The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. |
| 3 | Derivative | Stock Option (right to buy) | 2026-08-11 | M | D | 7,000 | $0.00 | 0 | D | $5.97 · — to 2026-08-16 | 7,000 Ordinary Shares | (F1) The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026. (F2) These stock options are fully vested. |